Email Us
HYGEA MEDICAL

DISCOVER
HYGEA MEDICAL

About Hygea Medical

ABOUT HYGEA

Hygea Medical, incorporated in 2010 and headquartered in Beijing, China, is an innovative enterprise dedicated to the research, development, and production of high-end medical devices in the field of percutaneous and transvascular intervention.


We boast advanced production equipment and processes, as well as a professional R&D team, continuously pursuing excellence and technological innovation.


We focus on product research and development, striving to provide global medical professionals and patients with the most advanced, safe, and convenient medical solutions.


We adhere to the business philosophy of "people-oriented, technology leading", and are committed to building a globally leading medical device brand. We focus on customer needs, listen to market voices, and take customer satisfaction as our success.


We sincerely welcome global customers to cooperate with us and jointly promote the development of the medical industry. We will continue to provide you with high-quality products and services, and escort your health.


Hygea Feature

  • VALUE

    Keep improving, customer-oriented

  • VISION

    Climbing the world's scientific and technological peak and driving innovation in medical device industry

  • MISSION

    Your health our concern

Hygea History

Hygea History

2010

Founding of HygeaMed in Beijing, focus on ''Minimally Invasive Oncology'' & ''Cryogenic Medicine''


2012

Beijing key laboratory of cryogenic biomedical engineering;

National hi-tech enterprise


2016

''Research on technological innovation, safety, efficacy and prognostic factors of cryoablation of liver cancer'' was awarded First Prize of Beijing Science and Technology Award


2017

Granted for CFDA green channel  for innovative medical devices and Class III MD Approval;

Series Pre-A round financing in August from CHUCHANG GROUP and Beijing Zhongguancun Development Qihang Industrial Investment Fund(LP)


2018

Series A round financing from Xinghe Capital 


2019

Series B round financing from Jianxing Medical Fund under CCB International, Samudrau Capital and STREAM V


2020

CE certification


2021

Series C+ round financing from Gaorong Capital;

Series C round financing from China Growth Capital, CHINA REFORM, BioTrack Capital, Sinopharm Capital, etc.


2022

Cryosurgical System ''AI Epic'' is granted for Class III MD Approval


Hygea Medical Technology Co., Ltd.
We are committed to building a platform-type innovative medical device enterprise for minimally invasive treatment, and helping China's medical devices and China's minimally invasive to realize the curved road to overtake.